Omid Harandi
About Omid Harandi
Omid Harandi serves as the Vice President of Research at SalioGen Therapeutics, a position he has held since 2022. He has an extensive background in stem cell research and genetics, with previous roles at prestigious institutions including Harvard Medical School and Penn State University.
Current Role at SalioGen Therapeutics
Omid Harandi serves as the Vice President of Research at SalioGen Therapeutics, a position he has held since 2022. In this role, he is responsible for overseeing research initiatives and guiding the development of innovative therapies. His tenure at SalioGen Therapeutics has been marked by a focus on advancing the company's research agenda in the field of genetic medicine. The company is located in Greater Boston, a hub for biotechnology and pharmaceutical research.
Previous Experience in Cell Therapy
Before becoming Vice President of Research, Omid Harandi worked at SalioGen Therapeutics as the Head of Cell Therapy for eight months in 2022. In this capacity, he led efforts in developing cell-based therapies, contributing to the company's strategic objectives in regenerative medicine. His experience in this role laid the groundwork for his current leadership position.
Academic Background and Research Fellowships
Omid Harandi has a strong academic background in genetics and stem cell research. He completed his Ph.D. in Genetics with a focus on Stem Cell and Hematopoiesis at Penn State University from 2001 to 2008. Following this, he held a postdoctoral fellowship in Molecular Medicine with a focus on Stem Cells at the University of Massachusetts Medical School from 2008 to 2012. Additionally, he served as a Research Fellow in Stem Cell-Hematology/Oncology at Harvard Medical School - BIDMC from 2013 to 2016.
Research Contributions and Fellowships
Throughout his academic career, Omid Harandi has contributed to various research initiatives in the field of genetics and stem cell biology. He also completed a fellowship in Plant Genetics at Penn State University, supported by the Vavilov-Frankel Award and Biodiversity International Organization, from 2000 to 2001. His diverse research experiences have equipped him with a comprehensive understanding of both human and plant genetics.